|
2024
|
Invention
|
Fixed dose combinations and formulations comprising etc1002 and one or more statins and methods o... |
|
|
Invention
|
Macrocyclic inhibitors of atp citrate lyase. The application relates to macrocyclic compounds of ... |
|
|
Invention
|
Compositions containing, and combination therapies using bempedoic acid and a glp-1 receptor agon... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of metabolic disease. |
|
|
G/S
|
promoting public awareness about treatments for metabolic diseases and disorders providing a webs... |
|
|
Invention
|
Methods of making bempedoic acid and compositions of the same.
The invention provides methods of... |
|
|
Invention
|
Fixed dose combinations and formulations comprising etc1002 and ezetimibe and methods of treating... |
|
2023
|
Invention
|
Methods of treatment using bempedoic acid.
Provided herein are methods of reducing the risk of m... |
|
|
Invention
|
Macrocyclic inhibitors of atp citrate lyase. The present disclosure provides, in part, compounds ... |
|
|
Invention
|
Methods of making bempedoic acid and compositions of the same. The invention provides methods of ... |
|
|
Invention
|
Methods of treatment using bempedoic acid. Provided herein are methods of reducing the risk of my... |
|
2022
|
Invention
|
Hydroxyl compounds and compositions for cholesterol management and related uses.
The present inv... |
|
|
Invention
|
Compositions containing and therapies using bempedoic acid and tolvaptan.
Provided herein are fi... |
|
|
Invention
|
Compositions containing and therapies using bempedoic acid and tolvaptan. Provided herein are fix... |
|
|
Invention
|
Pharmaceutical compositions comprising granulated bempedoic acid.
Herein disclosed are novel com... |
|
2020
|
G/S
|
Pharmaceutical preparations for the treatment of cardiovascular and metabolic diseases |
|
|
Invention
|
Salt forms of bempedoic acid and methods for using the same.
The invention provides crystalline ... |
|
|
Invention
|
Salt forms of bempedoic acid and methods for using the same. The invention provides crystalline s... |
|
|
G/S
|
Pharmaceutical preparations used to treat metabolic diseases. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of metabolic disease, namely, obesity, blood pressu... |
|
2019
|
Invention
|
Methods for reducing the risk of diabetes in patients being treated for high cholesterol-related ... |
|
|
Invention
|
Combination drug formulations for treating patients with cardiovascular disease and associated co... |
|
|
Invention
|
Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses.
The ... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of metabolic diseases. |
|
|
Invention
|
Sustained release formulations of bempedoic acid. Herein disclosed are sustained-release bempedoi... |
|
2018
|
G/S
|
pharmaceutical preparations for the treatment of metabolic disease |
|
|
Invention
|
Hydroxyl compounds and compositions for cholesterol management and related uses. The present inve... |
|
|
Invention
|
Fixed dose formulations. Herein disclosed are novel compositions comprising: Bempedoic acid and B... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of metabolic disease. |
|
|
Invention
|
Triplet combination formulations and methods for treating or reducing the risk of cardiovascular ... |
|
|
Invention
|
Triplet combination formulations and methods of treating or reducing the risk of cardiovascular d... |
|
2017
|
Invention
|
Fixed dose formulations.
Herein disclosed are novel compositions comprising: Bempedoic acid and ... |
|
2015
|
Invention
|
Carboxy-cyclopropyl undecanol compounds for treatment of liver disease and other medical disorder... |
|
2009
|
G/S
|
Pharmaceutical and veterinary preparations; dietetic substances adapted for medical use; nutraceu... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of metabolic diseases, namely, obesity, blood press... |
|
1998
|
G/S
|
Pharmaceutical preparations for the treatment of metabolic disease |
